 4D pharma PLC LON:DDD; NASDAQ:LBPS said it will collaborate with Parkinsons UK as it continues to advance into clinical trials a drug that treats neurodegenerative conditions such as Parkinsons. It is setting up a patient advisory board PAB with the non-profit group made up of people living with the disease that will provide a valuable patient-centric perspective on the potential treatment. 